BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9018336)

  • 1. Comparison of ras activation in prostate carcinoma in Japanese and American men.
    Konishi N; Hiasa Y; Tsuzuki T; Tao M; Enomoto T; Miller GJ
    Prostate; 1997 Jan; 30(1):53-7. PubMed ID: 9018336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men.
    Konishi N; Enomoto T; Buzard G; Ohshima M; Ward JM; Rice JM
    Cancer; 1992 May; 69(9):2293-9. PubMed ID: 1562975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients.
    Mariyama M; Kishi K; Nakamura K; Obata H; Nishimura S
    Jpn J Cancer Res; 1989 Jul; 80(7):622-6. PubMed ID: 2507485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International comparison on ras gene mutations in latent prostate carcinoma.
    Watanabe M; Shiraishi T; Yatani R; Nomura AM; Stemmermann GN
    Int J Cancer; 1994 Jul; 58(2):174-8. PubMed ID: 8026877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado.
    Enomoto T; Fujita M; Inoue M; Nomura T; Shroyer KR
    Am J Clin Pathol; 1995 Feb; 103(2):224-30. PubMed ID: 7856567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of adenomatous polyposis coli gene and ras oncogenes in Japanese prostate cancer.
    Suzuki H; Aida S; Akimoto S; Igarashi T; Yatani R; Shimazaki J
    Jpn J Cancer Res; 1994 Aug; 85(8):847-52. PubMed ID: 7928631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of ras genes are relatively frequent in Japanese prostate cancers: pointing to genetic differences between populations.
    Shiraishi T; Muneyuki T; Fukutome K; Ito H; Kotake T; Watanabe M; Yatani R
    Anticancer Res; 1998; 18(4B):2789-92. PubMed ID: 9713462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras gene mutations in non-small cell lung cancer in Japanese.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2001; 8(4):889-92. PubMed ID: 11410804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of K-ras gene mutations in lung carcinomas: correlation with gender, histological subtypes, and clinical outcome.
    Wang YC; Lee HS; Chen SK; Yang SC; Chen CY
    J Cancer Res Clin Oncol; 1998; 124(9):517-22. PubMed ID: 9808427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique GGT --> GTT mutation at K-ras codon 12 in six human pancreatic cancer cell lines from Chinese patients.
    Wei S; Liu T; Liu H; Gao J
    Chin Med J (Engl); 2003 Oct; 116(10):1585-7. PubMed ID: 14640107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infrequent RAS oncogene mutations in human prostate cancer.
    Moul JW; Friedrichs PA; Lance RS; Theune SM; Chang EH
    Prostate; 1992; 20(4):327-38. PubMed ID: 1608859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutation of the K-ras oncogene in pancreatic carcinoma, and application of its detection in pancreatic juice to diagnose pancreatic carcinoma].
    Sawabu N; Watanabe H; Yamaguchi Y; Okai T
    Nihon Rinsho; 1995 Feb; 53(2):511-7. PubMed ID: 7699881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis.
    Takahashi T; Munakata M; Ohtsuka Y; Nisihara H; Nasuhara Y; Kamachi-Satoh A; Dosaka-Akita H; Homma Y; Kawakami Y
    Cancer; 2002 Aug; 95(3):624-33. PubMed ID: 12209756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases.
    Ren YX; Xu GM; Li ZS; Song YG
    World J Gastroenterol; 2004 Mar; 10(6):881-4. PubMed ID: 15040037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ras gene mutations in human prostate cancer.
    Carter BS; Epstein JI; Isaacs WB
    Cancer Res; 1990 Nov; 50(21):6830-2. PubMed ID: 2208148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ras gene mutations in ethmoid sinus adenocarcinoma: prognostic implications.
    Pérez P; Dominguez O; González S; González S; Triviño A; Suárez C
    Cancer; 1999 Jul; 86(2):255-64. PubMed ID: 10421261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-ras gene point mutations and p21ras immunostaining in human ovarian tumors.
    Semczuk A; Postawski K; Przadka D; Rozynska K; Wrobel A; Korobowicz E
    Eur J Gynaecol Oncol; 2004; 25(4):484-8. PubMed ID: 15285310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low frequency of p53 and k-ras codon 12 mutations in non-small cell lung carcinoma (NSCLC) tumors and surgical margins.
    Vatan O; Bilaloglu R; Tunca B; Cecener G; Gebitekin C; Egeli U; Yakut T; Urer N
    Tumori; 2007; 93(5):473-7. PubMed ID: 18038880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas.
    Pergolizzi RG; Kreis W; Rottach C; Susin M; Broome JD
    Cancer Invest; 1993; 11(1):25-32. PubMed ID: 7678540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.